What Researchers Did
Researchers reviewed 495 children and young adolescents treated for acute lymphoblastic leukemia between 2000 and 2017 to see how often bone damage called osteonecrosis occurred, what was linked to it, and how patients did afterward.
What They Found
This clinical study of 495 young patients with acute lymphoblastic leukemia found that 23 (4.6 percent) developed osteonecrosis, and that it was linked to older age and a higher steroid dose. Older age had a p-value of less than 0.0001 and higher steroid dose had a p-value of 0.0013. All 23 patients received standard therapies, and hyperbaric oxygen therapy was also performed in 8 of them. At follow-up, 15 patients were stable: 6 had no symptoms, 5 had pain during activity, and 4 had mild limits on function. The abstract does not say how the other 8 patients did, and it does not compare the 8 who received hyperbaric oxygen with those who did not.
What This Means for Canadian Patients
The authors say screening MRI in patients without symptoms could allow earlier diagnosis of osteonecrosis, so that conservative treatment can start sooner. They state that hyperbaric oxygen therapy "could have beneficial effects" in these patients. That is a cautious statement, and the abstract gives no results showing that the therapy caused any improvement. It does not report the pressure or the number of sessions used.
Canadian Relevance
No direct Canadian connection identified.
Study Limitations
Only 8 of the 23 patients received hyperbaric oxygen therapy, and the abstract reports no comparison group and no outcome data for those 8 alone, so it cannot show whether the therapy changed their results.